NCT06754475 Effects of Upper Extremity Low Volume HIIT in Heart Failure
| NCT ID | NCT06754475 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tarsus University |
| Condition | High Intensity Interval Training |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-11-01 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was planned to investigate the effects of upper extremity low-volume high-intensity interval training (LV-HIIT) on physical and cognitive function in patients with heart failure with preserved ejection fraction(HFpEF).The research was planned as a randomized controlled trial. Patients with clinically stable HFpEF at cardiology clinic will be included in the study. These cases will be randomly divided into two groups: intervention group and control grup. After 8 weeks intervention physical functions before and after treatment; functional exercise capacity, arm exercise capacities , peripheral muscle strength , fatigue cognitive functions; anxiety and depression and fear of movement will be evaluated.
Eligibility Criteria
Inclusion Criteria: * Clinical condition stable for ≥4 weeks. * New York Heart Association functional classification I-II to III * Over 18 years old Exclusion Criteria: History of CABG surgery * Unstable angina pectoris * Severe arrhythmia * Acute pericarditis, endocarditis, myocarditis * Severe left ventricular failure (EF \<40%) * Acute pulmonary embolism * History of syncope * Dissecting aneurysm * Thrombophlebitis * Orthopedic disorders that may interfere with exercise * Uncontrolled hypertension, severe pulmonary arterial hypertension * Moderate-severe valve disease * Decompensated Congestive Heart Failure * Electrolyte abnormalities * Hypertrophic Cardiomyopathy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06754475 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying High Intensity Interval Training. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06754475 currently recruiting?
Yes, NCT06754475 is actively recruiting participants. Contact the research team at nrlbllr@gmail.com for enrollment information.
Where is the NCT06754475 trial being conducted?
This trial is being conducted at Mersin, Turkey (Türkiye), Yenişehir, Turkey (Türkiye).
Who is sponsoring the NCT06754475 clinical trial?
NCT06754475 is sponsored by Tarsus University. The trial plans to enroll 30 participants.